Genomic approaches to explore susceptibility and pathogenesis of alcohol use disorder and alcohol-associated liver disease.
Journal
Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946
Informations de publication
Date de publication:
02 Oct 2023
02 Oct 2023
Historique:
received:
24
05
2023
accepted:
13
08
2023
medline:
5
10
2023
pubmed:
5
10
2023
entrez:
5
10
2023
Statut:
aheadofprint
Résumé
Excessive alcohol use is a major risk factor for the development of an alcohol use disorder (AUD) and contributes to a wide variety of other medical illnesses, including alcohol-associated liver disease (ALD). Both AUD and ALD are complex and causally inter-related diseases, and multiple factors other than alcohol consumption are implicated in the disease pathogenesis. While the underlying pathophysiology of AUD and ALD is complex, there is substantial evidence for a genetic susceptibility of both diseases. Current genome wide association studies indicate that genes associated with clinical AUD only poorly overlap with genes identified for heavy drinking and, in turn, neither overlap with genes identified for ALD. Uncovering the main genetic factors will enable us to identify molecular drivers underlying the pathogenesis and discover potential targets for therapy and implement patient care early in disease progression. In this review, we described multiple genomic approaches and their implications to investigate the susceptibility and pathogenesis of both AUD and ALD. We concluded our review with a discussion of the knowledge gaps and future research on genomic studies in these two diseases.
Identifiants
pubmed: 37796138
doi: 10.1097/HEP.0000000000000617
pii: 01515467-990000000-00586
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAAA NIH HHS
ID : R01 AA023722
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA025208
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA026264
Pays : United States
Informations de copyright
Copyright © 2023 American Association for the Study of Liver Diseases.